Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 4 (2007), Issue 5 (May)

1. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
   J Surg Oncol, 95(6): 499-506. [Abstract] [Full-text]
2. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors.
   Genes Chromosomes Cancer, 46(7): 644-55. [Abstract] [Full-text]
3. Microarray analysis to reveal genes involved in colon carcinogenesis.
   Expert Opin Pharmacother, 8(7): 895-900. [Abstract] [Full-text]
4. Selection of relevant genes in cancer diagnosis based on their prediction accuracy.
   Artif Intell Med, 40(1): 29-44. [Abstract] [Full-text]
5. XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer.
   Cancer, 109(10): 1996-2003. [Abstract] [Full-text]
6. Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.
   Oncogene, 26(20): 2873-84. [Abstract] [Full-text]
7. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.
   Oncogene, 26(20): 2914-24. [Abstract] [Full-text]
8. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
   Cancer Res, 67(9): 4382-9. [Abstract] [Full-text]
9. Identification of epigenetically silenced genes in tumor endothelial cells.
   Cancer Res, 67(9): 4138-48. [Abstract] [Full-text]
10. The SIL gene is essential for mitotic entry and survival of cancer cells.
    Cancer Res, 67(9): 4022-7. [Abstract] [Full-text]
11. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
    Gene, 395(1): 8-14. [Abstract] [Full-text]
12. Surgery-derived reactive oxygen species produced by polymorphonuclear leukocytes promote tumor recurrence: studies in an in vitro model.
    J Surg Res, 140(1): 115-20. [Abstract] [Full-text]
13. Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cells.
    Cancer Lett, 251(2): 237-46. [Abstract] [Full-text]
14. Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors.
    Clin Cancer Res, 13(9): 2758-67. [Abstract] [Full-text]
15. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
    Postgrad Med J, 83(979): 338-43. [Abstract] [Full-text]
16. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Clin Genet, 71(5): 427-33. [Abstract] [Full-text]
17. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
    Gastroenterology, 132(6): 2208-25. [Abstract] [Full-text]
18. Onerous concomitant complications of ulcerative colitis: a case report.
    Z Gastroenterol, 45(5): 379-81. [Abstract] [Full-text]
19. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
    Biochem Biophys Res Commun, 358(1): 117-23. [Abstract] [Full-text]
20. BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees.
    J Invest Dermatol, 127(6): 1387-91. [Abstract] [Full-text]
21. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Cancer Immunol Immunother, 56(8): 1225-36. [Abstract] [Full-text]
22. MicroRNA-143 and -145 in colon cancer.
    DNA Cell Biol, 26(5): 311-20. [Abstract] [Full-text]
23. Surgical treatment for digestive cancer. Current issues - colon cancer.
    Dig Surg, 24(2): 108-14. [Abstract] [Full-text]
24. A 68-year-old man with COPD contemplating colon cancer surgery.
    JAMA, 297(19): 2121-30. [Abstract] [Full-text]
25. Perceptions of colon cancer screening by stage of screening test adoption.
    Cancer Nurs, 30(3): 178-85. [Abstract] [Full-text]
26. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.
    Cancer Res, 67(10): 4949-55. [Abstract] [Full-text]
27. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
    Cancer Res, 67(10): 4940-8. [Abstract] [Full-text]
28. Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer.
    Cancer Res, 67(10): 4860-8. [Abstract] [Full-text]
29. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells.
    Cancer Res, 67(10): 4700-8. [Abstract] [Full-text]
30. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
    Cancer Res, 67(10): 4620-9. [Abstract] [Full-text]
31. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.
    J Biol Chem, 282(21): 15541-9. [Abstract] [Full-text]
32. The role of cytoreductive surgery for colon cancer metastatic to the ovary.
    Gynecol Oncol, 105(3): 791-5. [Abstract] [Full-text]
33. Comparative genomic instabilities of thyroid and colon cancers.
    Arch Otolaryngol Head Neck Surg, 133(5): 457-63. [Abstract] [Full-text]
34. Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
    Cytometry A, 71(6): 361-70. [Abstract] [Full-text]
35. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?
    Gut, 56(6): 838-46. [Abstract] [Full-text]
36. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial.
    Ann Surg, 245(6): 858-63. [Abstract] [Full-text]
37. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.
    Ann Surg, 245(6): 846-57. [Abstract] [Full-text]
38. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer.
    Cancer, 109(11): 2161-70. [Abstract] [Full-text]
39. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression.
    J Pathol, 212(1): 83-90. [Abstract] [Full-text]
40. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression.
    J Cell Physiol, 212(1): 42-50. [Abstract] [Full-text]
41. Improved anti-cancer effect of interferon gene transfer by sustained expression using CpG-reduced plasmid DNA.
    Int J Cancer, 121(2): 401-6. [Abstract] [Full-text]
42. Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.
    J Gastroenterol, 42(5): 402-5. [Abstract] [Full-text]
43. Association of tannase-producing Staphylococcus lugdunensis with colon cancer and characterization of a novel tannase gene.
    J Gastroenterol, 42(5): 346-51. [Abstract] [Full-text]
44. Oral and maxillofacial manifestations of Gardner's syndrome associated with growth hormone deficiency: case report and literature review.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103(6): e30-4. [Abstract] [Full-text]
45. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells.
    J Biol Chem, 282(22): 16006-15. [Abstract] [Full-text]
46. Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis.
    Am J Gastroenterol, 102(6): 1284-90. [Abstract] [Full-text]
47. Novel small molecule induces p53-dependent apoptosis in human colon cancer cells.
    Biochem Biophys Res Commun, 358(3): 842-7. [Abstract] [Full-text]
48. Solution structure of the all L- and D-amino acid-substituted mucin 2 epitope peptides.
    Biochem Biophys Res Commun, 358(3): 739-42. [Abstract] [Full-text]
49. N-(4-iodophenyl)-N'-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice.
    Br J Cancer, 96(11): 1684-91. [Abstract] [Full-text]
50. Mesenteric extraskeletal osteosarcoma with telangiectatic features: a case report.
    BMC Cancer, 7: 82. [Abstract] [Full-text]
51. Colon cancer risk and different HRT formulations: a case-control study.
    BMC Cancer, 7: 76. [Abstract] [Full-text]
52. Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis.
    Hum Gene Ther, 18(5): 435-50. [Abstract] [Full-text]
53. Preoperative mechanical preparation of the colon: the patient's experience.
    BMC Surg, 7: 5. [Abstract] [Full-text]
54. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
    J Clin Oncol, 25(16): 2198-204. [Abstract] [Full-text]
55. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
    J Clin Oncol, 25(16): 2205-11. [Abstract] [Full-text]
56. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.
    FASEB J, 21(8): 1730-41. [Abstract] [Full-text]
57. A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice.
    Int J Cancer, 121(3): 506-13. [Abstract] [Full-text]
58. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Int J Cancer, 121(3): 555-8. [Abstract] [Full-text]
59. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer.
    Int J Cancer, 121(3): 486-94. [Abstract] [Full-text]
60. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
    Int J Cancer, 121(3): 567-75. [Abstract] [Full-text]
61. Role of S128R polymorphism of E-selectin in colon metastasis formation.
    Int J Cancer, 121(3): 528-35. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.